Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
Oncogene
|
May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
Alberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology
Damian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
Molecular Cancer Therapeutics
|
October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell Carcinoid
Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
European Urology Oncology
|
July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma
Renate Pichler, Nils C H van Creij, Laura S Mertens, et al.
NPJ Precision Oncology
|
September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Jingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Cancer
|
February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities
Sonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Hemasphere
|
February 21, 2022
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
Verena Petzer, Normann Steiner, Olga Angelova-Unterberger, et al.
The Oncologist
|
July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
Renate Pichler, Josef Fritz, Andrea Mari, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
Oncogene
|
May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
Alberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology
Damian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
Molecular Cancer Therapeutics
|
October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell Carcinoid
Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
European Urology Oncology
|
July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma
Renate Pichler, Nils C H van Creij, Laura S Mertens, et al.
NPJ Precision Oncology
|
September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Jingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Cancer
|
February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities
Sonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Hemasphere
|
February 21, 2022
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
Verena Petzer, Normann Steiner, Olga Angelova-Unterberger, et al.
The Oncologist
|
July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
Renate Pichler, Josef Fritz, Andrea Mari, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Page
of 12